Sanofi to acquire Translate Bio
Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas
05-Aug-2021 -
As part of Sanofi’s endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics and vaccines, the company has entered into a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutics company, under which Sanofi will acquire all outstanding shares of ...
acquisitions
mRNA therapies